GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Feng Chi Biotech Corp (ROCO:6744) » Definitions » Total Liabilities

Feng Chi Biotech (ROCO:6744) Total Liabilities : NT$63.0 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Feng Chi Biotech Total Liabilities?

Feng Chi Biotech's Total Liabilities for the quarter that ended in Dec. 2023 was NT$63.0 Mil.

Feng Chi Biotech's quarterly Total Liabilities increased from Dec. 2022 (NT$72.49 Mil) to Jun. 2023 (NT$82.93 Mil) but then declined from Jun. 2023 (NT$82.93 Mil) to Dec. 2023 (NT$63.03 Mil).

Feng Chi Biotech's annual Total Liabilities increased from Dec. 2021 (NT$56.18 Mil) to Dec. 2022 (NT$72.49 Mil) but then declined from Dec. 2022 (NT$72.49 Mil) to Dec. 2023 (NT$63.03 Mil).


Feng Chi Biotech Total Liabilities Historical Data

The historical data trend for Feng Chi Biotech's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Feng Chi Biotech Total Liabilities Chart

Feng Chi Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial 53.78 58.91 56.18 72.49 63.03

Feng Chi Biotech Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.18 70.65 72.49 82.93 63.03

Feng Chi Biotech Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Feng Chi Biotech's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=54.798+(8.149+0.086999999999998
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=63.0

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=301.032-237.998
=63.0

Feng Chi Biotech's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=54.798+(8.149+0.086999999999998
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=63.0

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=301.032-237.998
=63.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Feng Chi Biotech Total Liabilities Related Terms

Thank you for viewing the detailed overview of Feng Chi Biotech's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Feng Chi Biotech (ROCO:6744) Business Description

Traded in Other Exchanges
N/A
Address
No. 5, Shaoxing North Street, 5th Floor-1, Zhongzheng District, Taipei City, TWN, 100
Feng Chi Biotech Corp provide promotion and support for clinical testing and molecular genetic medicine research related technologies. The company's products and services include clinical testing, food testing, newborn screening, prenatal screening, iron stomach, interscience, and colony counting.

Feng Chi Biotech (ROCO:6744) Headlines

No Headlines